Date published: 2026-5-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

NEDL1 Inhibitors

NEDL1 inhibitors pertain to a category of chemical compounds designed to selectively block or impede the activity of NEDL1 (Neural precursor cell Expressed Developmentally Down-regulated protein 4-like), which is a specific E3 ubiquitin ligase enzyme. E3 ubiquitin ligases are crucial components of the ubiquitin-proteasome system, responsible for regulating the degradation of proteins within cells. NEDL1, a member of the NEDD4-like family of E3 ligases, plays a role in the ubiquitination and subsequent degradation of target proteins. Inhibiting NEDL1 activity can have profound effects on protein turnover and cellular processes that rely on precise protein regulation.

Researchers use NEDL1 inhibitors as valuable tools in molecular biology and cell biology studies to elucidate the function of NEDL1 and its substrates. By selectively interfering with NEDL1 activity, scientists can investigate the impact on protein stability and degradation pathways. This, in turn, provides insights into the cellular functions and regulatory mechanisms controlled by NEDL1. Moreover, NEDL1 inhibitors can be used to explore the roles of NEDL1 in various biological processes, including cell signaling, protein homeostasis, and cell cycle regulation. Understanding the intricate details of NEDL1-mediated ubiquitination can have broad implications in deciphering the molecular basis of numerous diseases and cellular functions, thereby contributing to advancements in basic research.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

A peptide aldehyde that inhibits the proteasome and could indirectly affect the stability and expression of E3 ligases like NEDL1.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

A proteasome inhibitor that could impact E3 ligase function and expression by disrupting proteasomal degradation pathways.

Carfilzomib

868540-17-4sc-396755
5 mg
$41.00
(0)

An irreversible proteasome inhibitor that could affect the expression of ubiquitin ligases through proteome-wide effects.

MLN 4924

905579-51-3sc-484814
1 mg
$286.00
1
(0)

An inhibitor of NEDD8-activating enzyme that could decrease the neddylation and activity of certain E3 ligases.

Ubiquitin E1 Inhibitor, PYR-41

418805-02-4sc-358737
25 mg
$360.00
4
(1)

An irreversible inhibitor of the ubiquitin-activating enzyme E1, potentially reducing the ubiquitination activity of ligases like NEDL1.

IU1

314245-33-5sc-361215
sc-361215A
sc-361215B
10 mg
50 mg
100 mg
$138.00
$607.00
$866.00
2
(0)

A specific inhibitor of USP14, a proteasome-associated deubiquitinase, which could affect ubiquitin ligase function indirectly.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$188.00
$575.00
60
(2)

Metabolite of lactacystin that acts as a proteasome inhibitor, possibly influencing ubiquitin ligase expression.

Oprozomib

935888-69-0sc-477447
2.5 mg
$280.00
(0)

A bioavailable proteasome inhibitor that could affect the activity and expression of E3 ligases.

Epoxomicin

134381-21-8sc-201298C
sc-201298
sc-201298A
sc-201298B
50 µg
100 µg
250 µg
500 µg
$137.00
$219.00
$449.00
$506.00
19
(2)

A selective proteasome inhibitor that may alter the expression of proteins involved in the ubiquitination pathway.

Withaferin A

5119-48-2sc-200381
sc-200381A
sc-200381B
sc-200381C
1 mg
10 mg
100 mg
1 g
$130.00
$583.00
$4172.00
$20506.00
20
(1)

A steroidal lactone that has been shown to inhibit proteasomal activity, potentially impacting E3 ligase function.